The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in Myo-Inositol Chemistry)

Overview

Journal Angew Chem Int Ed Engl

Specialty Chemistry

Date 2015 Dec 24

PMID 26694856

Citations 52

Authors

Mark P Thomas

Stephen J Mills

Barry V L Potter

Affiliations

Soon will be listed here.

Abstract

Cell signaling via inositol phosphates, in particular via the second messenger myo-inositol 1,4,5-trisphosphate, and phosphoinositides comprises a huge field of biology. Of the nine 1,2,3,4,5,6-cyclohexanehexol isomers, myo-inositol is pre-eminent, with "other" inositols (cis-, epi-, allo-, muco-, neo-, L-chiro-, D-chiro-, and scyllo-) and derivatives rarer or thought not to exist in nature. However, neo- and d-chiro-inositol hexakisphosphates were recently revealed in both terrestrial and aquatic ecosystems, thus highlighting the paucity of knowledge of the origins and potential biological functions of such stereoisomers, a prevalent group of environmental organic phosphates, and their parent inositols. Some "other" inositols are medically relevant, for example, scyllo-inositol (neurodegenerative diseases) and d-chiro-inositol (diabetes). It is timely to consider exploration of the roles and applications of the "other" isomers and their derivatives, likely by exploiting techniques now well developed for the myo series.

Citing Articles

Metabolomic profiling identifies novel metabolites associated with cardiac dysfunction.

Culler K, Sinha A, Filipp M, Giro P, Allen N, Taylor K Sci Rep. 2024; 14(1):20694.

PMID: 39237673 PMC: 11377834. DOI: 10.1038/s41598-024-71329-y.

Efficient pathway-driven -inositol production from -inositol using thermophilic cells and mesophilic inositol dehydrogenases: a novel strategy for pathway control.

Kurashiki R, Takahashi M, Okumura Y, Ono T, Endo H, Makino K Appl Environ Microbiol. 2024; 90(7):e0028124.

PMID: 38975762 PMC: 11267878. DOI: 10.1128/aem.00281-24.

Deciphering the potential of extract: metabolic profiling and pathway analysis of groundnut () in response to extract and .

Akhyani D, Agarwal P, Mesara S, Agarwal P Physiol Mol Biol Plants. 2024; 30(2):317-336.

PMID: 38623170 PMC: 11016048. DOI: 10.1007/s12298-024-01418-9.

Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring.

Wang W, Zhen S, Ping Y, Wang L, Zhang Y Front Oncol. 2024; 14:1331215.

PMID: 38384814 PMC: 10879439. DOI: 10.3389/fonc.2024.1331215.

Substrate promiscuity of inositol 1,4,5-trisphosphate kinase driven by structurally-modified ligands and active site plasticity.

Marquez-Monino M, Ortega-Garcia R, Whitfield H, Riley A, Infantes L, Garrett S Nat Commun. 2024; 15(1):1502.

PMID: 38374076 PMC: 10876669. DOI: 10.1038/s41467-024-45917-5.

References

Vandeput F, Combettes L, Mills S, Backers K, Wohlkonig A, Parys J . Biphenyl 2,3',4,5',6-pentakisphosphate, a novel inositol polyphosphate surrogate, modulates Ca2+ responses in rat hepatocytes. FASEB J. 2007; 21(7):1481-91. DOI: 10.1096/fj.06-7691com. View

Michaelis T, Helms G, Merboldt K, Hanicke W, Bruhn H, Frahm J . Identification of Scyllo-inositol in proton NMR spectra of human brain in vivo. NMR Biomed. 1993; 6(1):105-9. DOI: 10.1002/nbm.1940060116. View

Rae C . A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res. 2013; 39(1):1-36. DOI: 10.1007/s11064-013-1199-5. View

Kofman O, Sherman W, Katz V, Belmaker R . Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures. Psychopharmacology (Berl). 1993; 110(1-2):229-34. DOI: 10.1007/BF02246978. View

Unfer V, Porcaro G . Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Rev Clin Pharmacol. 2014; 7(5):623-31. DOI: 10.1586/17512433.2014.925795. View

Shaldubina A, Ju S, Vaden D, Ding D, Belmaker R, Greenberg M . Epi-inositol regulates expression of the yeast INO1 gene encoding inositol-1-P synthase. Mol Psychiatry. 2002; 7(2):174-80. DOI: 10.1038/sj.mp.4000965. View

Liu C, Al-Hafidh J, Westwick J, Potter B . Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor. Bioorg Med Chem. 1994; 2(4):253-7. DOI: 10.1016/s0968-0896(00)82168-9. View

Wu M, Dul B, Trevisan A, Fiedler D . Synthesis and characterization of non-hydrolysable diphosphoinositol polyphosphate second messengers. Chem Sci. 2013; 4(1):405-410. PMC: 3558982. DOI: 10.1039/C2SC21553E. View

Keddie N, Ye Y, Aslam T, Luyten T, Bello D, Garnham C . Development of inositol-based antagonists for the D-myo-inositol 1,4,5-trisphosphate receptor. Chem Commun (Camb). 2010; 47(1):242-4. DOI: 10.1039/c0cc03003a. View

10.

Rao F, Xu J, Fu C, Cha J, Gadalla M, Xu R . Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1. Proc Natl Acad Sci U S A. 2015; 112(6):1773-8. PMC: 4330756. DOI: 10.1073/pnas.1424642112. View

11.

Hoglinger D, Nadler A, Schultz C . Caged lipids as tools for investigating cellular signaling. Biochim Biophys Acta. 2014; 1841(8):1085-96. DOI: 10.1016/j.bbalip.2014.03.012. View

12.

Tsui M, York J . Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes. Adv Enzyme Regul. 2009; 50(1):324-37. PMC: 3269838. DOI: 10.1016/j.advenzreg.2009.12.002. View

13.

Menniti F, MILLER R, Putney Jr J, Shears S . Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells. J Biol Chem. 1993; 268(6):3850-6. View

14.

Saleem H, Tovey S, Riley A, Potter B, Taylor C . Stimulation of inositol 1,4,5-trisphosphate (IP3) receptor subtypes by adenophostin A and its analogues. PLoS One. 2013; 8(2):e58027. PMC: 3585173. DOI: 10.1371/journal.pone.0058027. View

15.

Marnera G, dAlarcao M . Synthesis of galactosaminyl D-chiro-inositols. Carbohydr Res. 2006; 341(9):1105-16. DOI: 10.1016/j.carres.2006.03.031. View

16.

Miethchen R, Sowa C, Frank M, Michalik M, Reinke H . Selective epimerization of L-chiro-inositol to L-muco- and D-chiro-inositol derivatives. Carbohydr Res. 2002; 337(1):1-9. DOI: 10.1016/s0008-6215(01)00281-6. View

17.

Taguchi R, Yamazaki J, Tsutsui Y, Ikezawa H . Identification of chiro-inositol and its formation by isomerization of myo-inositol during hydrolysis of glycosylphosphatidylinositol-anchored proteins. Arch Biochem Biophys. 1997; 342(1):161-8. DOI: 10.1006/abbi.1997.9991. View

18.

Michell R . Evolution of the diverse biological roles of inositols. Biochem Soc Symp. 2007; (74):223-46. DOI: 10.1042/BSS0740223. View

19.

Adams G, Imran S, Wang S, Mohammad A, Kok M, Gray D . The hypoglycemic effect of pumpkin seeds, Trigonelline (TRG), Nicotinic acid (NA), and D-Chiro-inositol (DCI) in controlling glycemic levels in diabetes mellitus. Crit Rev Food Sci Nutr. 2014; 54(10):1322-9. DOI: 10.1080/10408398.2011.635816. View

20.

Shaltiel G, Dalton E, Belmaker R, Harwood A, Agam G . Specificity of mood stabilizer action on neuronal growth cones. Bipolar Disord. 2007; 9(3):281-9. DOI: 10.1111/j.1399-5618.2007.00400.x. View